These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 26880380)

  • 1. Development of Photoactivatable Allosteric Modulators for the Chemokine Receptor CXCR3.
    Admas TH; Bernat V; Heinrich MR; Tschammer N
    ChemMedChem; 2016 Mar; 11(6):575-84. PubMed ID: 26880380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and application of the first radioligand targeting the allosteric binding pocket of chemokine receptor CXCR3.
    Bernat V; Heinrich MR; Baumeister P; Buschauer A; Tschammer N
    ChemMedChem; 2012 Aug; 7(8):1481-9. PubMed ID: 22689503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular Mechanisms of Biased and Probe-Dependent Signaling at CXC-Motif Chemokine Receptor CXCR3 Induced by Negative Allosteric Modulators.
    Brox R; Milanos L; Saleh N; Baumeister P; Buschauer A; Hofmann D; Heinrich MR; Clark T; Tschammer N
    Mol Pharmacol; 2018 Apr; 93(4):309-322. PubMed ID: 29343553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of overlapping but differential binding sites for the high-affinity CXCR3 antagonists NBI-74330 and VUF11211.
    Scholten DJ; Roumen L; Wijtmans M; Verkade-Vreeker MC; Custers H; Lai M; de Hooge D; Canals M; de Esch IJ; Smit MJ; de Graaf C; Leurs R
    Mol Pharmacol; 2014 Jan; 85(1):116-26. PubMed ID: 24174496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Two Distinct Sites for Antagonist and Biased Agonist Binding to the Human Chemokine Receptor CXCR3.
    Milanos L; Saleh N; Kling RC; Kaindl J; Tschammer N; Clark T
    Angew Chem Int Ed Engl; 2016 Dec; 55(49):15277-15281. PubMed ID: 27862735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological characterization of [3H]VUF11211, a novel radiolabeled small-molecule inverse agonist for the chemokine receptor CXCR3.
    Scholten DJ; Wijtmans M; van Senten JR; Custers H; Stunnenberg A; de Esch IJ; Smit MJ; Leurs R
    Mol Pharmacol; 2015 Apr; 87(4):639-48. PubMed ID: 25576486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noncompetitive antagonism and inverse agonism as mechanism of action of nonpeptidergic antagonists at primate and rodent CXCR3 chemokine receptors.
    Verzijl D; Storelli S; Scholten DJ; Bosch L; Reinhart TA; Streblow DN; Tensen CP; Fitzsimons CP; Zaman GJ; Pease JE; de Esch IJ; Smit MJ; Leurs R
    J Pharmacol Exp Ther; 2008 May; 325(2):544-55. PubMed ID: 18270317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ligand-biased and probe-dependent modulation of chemokine receptor CXCR3 signaling by negative allosteric modulators.
    Bernat V; Brox R; Heinrich MR; Auberson YP; Tschammer N
    ChemMedChem; 2015 Mar; 10(3):566-74. PubMed ID: 25655398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological characterization of CXC chemokine receptor 3 ligands and a small molecule antagonist.
    Heise CE; Pahuja A; Hudson SC; Mistry MS; Putnam AL; Gross MM; Gottlieb PA; Wade WS; Kiankarimi M; Schwarz D; Crowe P; Zlotnik A; Alleva DG
    J Pharmacol Exp Ther; 2005 Jun; 313(3):1263-71. PubMed ID: 15761110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological characterization of a small-molecule agonist for the chemokine receptor CXCR3.
    Scholten DJ; Canals M; Wijtmans M; de Munnik S; Nguyen P; Verzijl D; de Esch IJ; Vischer HF; Smit MJ; Leurs R
    Br J Pharmacol; 2012 Jun; 166(3):898-911. PubMed ID: 21883151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and structure-activity relationships of 3H-quinazolin-4-ones and 3H-pyrido[2,3-d]pyrimidin-4-ones as CXCR3 receptor antagonists.
    Storelli S; Verzijl D; Al-Badie J; Elders N; Bosch L; Timmerman H; Smit MJ; De Esch IJ; Leurs R
    Arch Pharm (Weinheim); 2007 Jun; 340(6):281-91. PubMed ID: 17562560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Boronic acids as probes for investigation of allosteric modulation of the chemokine receptor CXCR3.
    Bernat V; Admas TH; Brox R; Heinemann FW; Tschammer N
    ACS Chem Biol; 2014 Nov; 9(11):2664-77. PubMed ID: 25233453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a photoactivatable allosteric ligand for the m1 muscarinic acetylcholine receptor.
    Davie BJ; Sexton PM; Capuano B; Christopoulos A; Scammells PJ
    ACS Chem Neurosci; 2014 Oct; 5(10):902-7. PubMed ID: 25188871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An inhibitory metabolite leads to dose- and time-dependent pharmacokinetics of (R)-N-{1-[3-(4-ethoxy-phenyl)-4-oxo-3,4-dihydro-pyrido[2,3-d]pyrimidin-2-yl]-ethyl}-N-pyridin-3-yl-methyl-2-(4-trifluoromethoxy-phenyl)-acetamide (AMG 487) in human subjects after multiple dosing.
    Tonn GR; Wong SG; Wong SC; Johnson MG; Ma J; Cho R; Floren LC; Kersey K; Berry K; Marcus AP; Wang X; Van Lengerich B; Medina JC; Pearson PG; Wong BK
    Drug Metab Dispos; 2009 Mar; 37(3):502-13. PubMed ID: 19088267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequential metabolism of AMG 487, a novel CXCR3 antagonist, results in formation of quinone reactive metabolites that covalently modify CYP3A4 Cys239 and cause time-dependent inhibition of the enzyme.
    Henne KR; Tran TB; VandenBrink BM; Rock DA; Aidasani DK; Subramanian R; Mason AK; Stresser DM; Teffera Y; Wong SG; Johnson MG; Chen X; Tonn GR; Wong BK
    Drug Metab Dispos; 2012 Jul; 40(7):1429-40. PubMed ID: 22517972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CXCR3 antagonist VUF10085 binds to an intrahelical site distinct from that of the broad spectrum antagonist TAK-779.
    Nedjai B; Viney JM; Li H; Hull C; Anderson CA; Horie T; Horuk R; Vaidehi N; Pease JE
    Br J Pharmacol; 2015 Apr; 172(7):1822-33. PubMed ID: 25425280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Label-free impedance responses of endogenous and synthetic chemokine receptor CXCR3 agonists correlate with Gi-protein pathway activation.
    Watts AO; Scholten DJ; Heitman LH; Vischer HF; Leurs R
    Biochem Biophys Res Commun; 2012 Mar; 419(2):412-8. PubMed ID: 22349504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clickable Photoaffinity Ligands for Metabotropic Glutamate Receptor 5 Based on Select Acetylenic Negative Allosteric Modulators.
    Gregory KJ; Velagaleti R; Thal DM; Brady RM; Christopoulos A; Conn PJ; Lapinsky DJ
    ACS Chem Biol; 2016 Jul; 11(7):1870-9. PubMed ID: 27115427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CXCL11 promotes tumor progression by the biased use of the chemokine receptors CXCR3 and CXCR7.
    Puchert M; Obst J; Koch C; Zieger K; Engele J
    Cytokine; 2020 Jan; 125():154809. PubMed ID: 31437604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small Molecule CXCR3 Antagonists.
    Andrews SP; Cox RJ
    J Med Chem; 2016 Apr; 59(7):2894-917. PubMed ID: 26535614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.